Page last updated: 2024-09-04

aclacinomycin and Leukemia, Myeloid

aclacinomycin has been researched along with Leukemia, Myeloid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aries, A; Chenais, B; Devy, L; Gillet, R; Jeannesson, P; Lahlil, R; Morceau, F; Trentesaux, C1
Ishii, E; Kato, Y; Matsuzaki, A; Miyazaki, S; Ueda, K1

Reviews

1 review(s) available for aclacinomycin and Leukemia, Myeloid

ArticleYear
Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.
    Leukemia & lymphoma, 1997, Volume: 26, Issue:5-6

    Topics: Aclarubicin; Antibiotics, Antineoplastic; Carbohydrate Sequence; Cell Differentiation; Doxorubicin; Erythroid Precursor Cells; Gene Expression Regulation, Leukemic; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Molecular Sequence Data

1997

Other Studies

1 other study(ies) available for aclacinomycin and Leukemia, Myeloid

ArticleYear
Treatment of juvenile chronic myelocytic leukemia with multidrug chemotherapy including aclacinomycin and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1986, Volume: 49, Issue:6

    Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Humans; Leukemia, Myeloid; Male; Naphthacenes

1986